Amid a raging controversy over
the efficacy of Covaxin, Indiaâ€™s first indigenous Covid-19 vaccine
reputed medical journal the Lancet Infectious Diseases on Friday said the vaccine Friday said the vaccine produced
tolerable safety outcomes a and enhanced immune responses in its Phase 1 trials